Sealed Air beats Q4 estimates as $42.15 CD&R takeover caps upside
Packaging maker posts strong quarterly results but shares hover near acquisition price with deal closing mid-2026
Sealed Air Corporation reported stronger-than-expected fourth quarter earnings, but shares remain constrained by the company's pending $10.3 billion acquisition by private equity firm Clayton, Dubilier & Rice.
The packaging manufacturer delivered adjusted earnings per share of $0.77 for the final quarter of 2025, beating analyst estimates of $0.73, according to data compiled by Benzinga. Revenue increased 2% to $1.40 billion, exceeding projections of $1.34 billion.
Despite the solid performance, Sealed Air shares closed at $41.88, trading just below the $42.15 per share that CD&R agreed to pay in the all-cash transaction announced in November 2025. The deal received shareholder approval in late February and cleared European Commission regulatory review, with closing expected by mid-2026.
"Our fourth quarter performance demonstrates the strength of our portfolio and operational execution," the company stated in its earnings release. The Protective segment emerged as a standout performer, with adjusted EBITDA jumping 21% to $80 million, representing 17.3% of net sales. The segment achieved a 3% increase in net sales to $464 million on a reported basis.
The Food segment, Sealed Air's largest business unit, generated $937 million in revenue, up 2% as reported. However, adjusted EBITDA declined 3% to $202 million, representing a 21.6% margin. On a constant currency basis, both segments experienced slight volume pressure.
Analysts at Raymond James and Baird downgraded the stock to "Market Perform" and "Neutral" respectively following the acquisition announcement, citing the limited upside potential relative to the takeover price. The deal represents approximately a 10% premium to Sealed Air's trading level before the agreement was revealed.
The Charlotte-based company, known for its Bubble Wrap protective packaging and Cryovac food packaging brands, has been working to streamline operations and reduce debt. Net leverage improved to 3.2x from 3.6x, positioning the company favorably ahead of going private.
The $10.3 billion transaction, which includes assumption of debt, will take Sealed Air private and remove its shares from the New York Stock Exchange upon closing. CD&R, which specializes in industrial and healthcare investments, has identified operational efficiency improvements and expansion into adjacent markets as key value creation opportunities.
With the acquisition price establishing a firm ceiling on the stock's trading range until deal completion, investors are focused on execution risk and regulatory clearance. The European Commission's approval in late February removed a significant hurdle, though remaining regulatory reviews in other jurisdictions must still be completed.
Sealed Air's next quarterly dividend of $0.20 per share is scheduled for payment on March 27, offering existing shareholders a modest return while they await deal closing. The annual dividend yield stands at 1.9%.